Global Biologics Outsourcing Market Overview:
Global Biologics Outsourcing Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Biologics Outsourcing Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Biologics Outsourcing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Biologics Outsourcing Market:
The Biologics Outsourcing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Biologics Outsourcing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Biologics Outsourcing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Biologics Outsourcing market has been segmented into:
Product
(Antibodies
Recombinant Proteins
Vaccines
Others
By Application, Biologics Outsourcing market has been segmented into:
Cell Development
Process Development
Analytical Testing
cGMP Manufacturing
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biologics Outsourcing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biologics Outsourcing market.
Top Key Players Covered in Biologics Outsourcing market are:
Thermo Fisher Scientific Inc.
Abzena Ltd. Fujifilm Diosynth Biotechnologies
KBI Biopharma
EirGenix
Inc.
Curia Global
Inc.
Bionova Scientific
Inc.
Boehringer Ingelheim International GmbH.
STC Biologics.
Abbvie Inc.
Avid Bioservices
Inc.
Catalent Inc.
Emergent
Eurofins Scientific
Genentech
Inc.
Genscript Biotech Corporation
JSR Corporation
Lonza
Merck KGaA
Rentschler Biopharma SE.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Biologics Outsourcing Market by Type
4.1 Biologics Outsourcing Market Snapshot and Growth Engine
4.2 Biologics Outsourcing Market Overview
4.3 Product
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Product: Geographic Segmentation Analysis
4.4 (Antibodies
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 (Antibodies: Geographic Segmentation Analysis
4.5 Recombinant Proteins
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Recombinant Proteins: Geographic Segmentation Analysis
4.6 Vaccines
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Vaccines: Geographic Segmentation Analysis
4.7 Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Others: Geographic Segmentation Analysis
Chapter 5: Biologics Outsourcing Market by Application
5.1 Biologics Outsourcing Market Snapshot and Growth Engine
5.2 Biologics Outsourcing Market Overview
5.3 Cell Development
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cell Development: Geographic Segmentation Analysis
5.4 Process Development
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Process Development: Geographic Segmentation Analysis
5.5 Analytical Testing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Analytical Testing: Geographic Segmentation Analysis
5.6 cGMP Manufacturing
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 cGMP Manufacturing: Geographic Segmentation Analysis
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Biologics Outsourcing Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 THERMO FISHER SCIENTIFIC INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ABZENA LTD. FUJIFILM DIOSYNTH BIOTECHNOLOGIES
6.4 KBI BIOPHARMA
6.5 EIRGENIX
6.6 INC.
6.7 CURIA GLOBAL
6.8 INC.
6.9 BIONOVA SCIENTIFIC
6.10 INC.
6.11 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
6.12 STC BIOLOGICS.
6.13 ABBVIE INC.
6.14 AVID BIOSERVICES
6.15 INC.
6.16 CATALENT INC.
6.17 EMERGENT
6.18 EUROFINS SCIENTIFIC
6.19 GENENTECH
6.20 INC.
6.21 GENSCRIPT BIOTECH CORPORATION
6.22 JSR CORPORATION
6.23 LONZA
6.24 MERCK KGAA
6.25 RENTSCHLER BIOPHARMA SE.
Chapter 7: Global Biologics Outsourcing Market By Region
7.1 Overview
7.2. North America Biologics Outsourcing Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Product
7.2.4.2 (Antibodies
7.2.4.3 Recombinant Proteins
7.2.4.4 Vaccines
7.2.4.5 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Cell Development
7.2.5.2 Process Development
7.2.5.3 Analytical Testing
7.2.5.4 cGMP Manufacturing
7.2.5.5 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Biologics Outsourcing Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Product
7.3.4.2 (Antibodies
7.3.4.3 Recombinant Proteins
7.3.4.4 Vaccines
7.3.4.5 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Cell Development
7.3.5.2 Process Development
7.3.5.3 Analytical Testing
7.3.5.4 cGMP Manufacturing
7.3.5.5 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Biologics Outsourcing Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Product
7.4.4.2 (Antibodies
7.4.4.3 Recombinant Proteins
7.4.4.4 Vaccines
7.4.4.5 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Cell Development
7.4.5.2 Process Development
7.4.5.3 Analytical Testing
7.4.5.4 cGMP Manufacturing
7.4.5.5 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Biologics Outsourcing Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Product
7.5.4.2 (Antibodies
7.5.4.3 Recombinant Proteins
7.5.4.4 Vaccines
7.5.4.5 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Cell Development
7.5.5.2 Process Development
7.5.5.3 Analytical Testing
7.5.5.4 cGMP Manufacturing
7.5.5.5 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Biologics Outsourcing Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Product
7.6.4.2 (Antibodies
7.6.4.3 Recombinant Proteins
7.6.4.4 Vaccines
7.6.4.5 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Cell Development
7.6.5.2 Process Development
7.6.5.3 Analytical Testing
7.6.5.4 cGMP Manufacturing
7.6.5.5 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Biologics Outsourcing Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Product
7.7.4.2 (Antibodies
7.7.4.3 Recombinant Proteins
7.7.4.4 Vaccines
7.7.4.5 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Cell Development
7.7.5.2 Process Development
7.7.5.3 Analytical Testing
7.7.5.4 cGMP Manufacturing
7.7.5.5 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Biologics Outsourcing Scope:
|
Report Data
|
Biologics Outsourcing Market
|
|
Biologics Outsourcing Market Size in 2025
|
USD XX million
|
|
Biologics Outsourcing CAGR 2025 - 2032
|
XX%
|
|
Biologics Outsourcing Base Year
|
2024
|
|
Biologics Outsourcing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific Inc., Abzena Ltd. Fujifilm Diosynth Biotechnologies, KBI Biopharma, EirGenix, Inc., Curia Global, Inc., Bionova Scientific, Inc., Boehringer Ingelheim International GmbH., STC Biologics., Abbvie Inc., Avid Bioservices, Inc., Catalent Inc., Emergent, Eurofins Scientific, Genentech, Inc., Genscript Biotech Corporation, JSR Corporation, Lonza, Merck KGaA, Rentschler Biopharma SE..
|
|
Key Segments
|
By Type
Product
(Antibodies
Recombinant Proteins
Vaccines
Others
By Applications
Cell Development
Process Development
Analytical Testing
cGMP Manufacturing
Others
|
